Wolfgang Hilbe

5.7k total citations · 1 hit paper
129 papers, 3.9k citations indexed

About

Wolfgang Hilbe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Wolfgang Hilbe has authored 129 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 49 papers in Pulmonary and Respiratory Medicine and 41 papers in Molecular Biology. Recurrent topics in Wolfgang Hilbe's work include Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Wolfgang Hilbe is often cited by papers focused on Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Wolfgang Hilbe collaborates with scholars based in Austria, Switzerland and Germany. Wolfgang Hilbe's co-authors include Michael Fiegl, Herbert Jamnig, Thomas Schmid, Andreas Pircher, H. Denz, Martin Hackl, Clemens Ager, Alexandar Tzankov, Ewald Wöll and Elfriede Ruttmann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Wolfgang Hilbe

122 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Noninvasive detection of lung cancer by analysis of exhaled breath

2009 480 citations Clemens Ager, Wojciech Filipiak et al. profile →

Peers

Countries citing papers authored by Wolfgang Hilbe

Since Specialization

Citations

This map shows the geographic impact of Wolfgang Hilbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Hilbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Hilbe more than expected).

Fields of papers citing papers by Wolfgang Hilbe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Hilbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Hilbe. The network helps show where Wolfgang Hilbe may publish in the future.

Co-authorship network of co-authors of Wolfgang Hilbe

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Hilbe. A scholar is included among the top collaborators of Wolfgang Hilbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Hilbe. Wolfgang Hilbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunosuppression for Immune Checkpoint-related Toxicity Can Cause Pneumocystis Jirovecii Pneumonia (PJP) in Non–small-cell Lung Cancer (NSCLC): A Report of 2 Cases 2018 ·Clinical Lung Cancer ·Michael Schwarz, Florian Kocher, (unknown), Jakob Rudzki, Maximilian J. Hochmair, Gerlig Widmann, Wolfgang Hilbe, Andreas Pircher	21
2	Development of a 3D angiogenesis model to study tumour – endothelial cell interactions and the effects of anti-angiogenic drugs 2017 ·Scientific Reports ·Arno Amann, Marit Zwierzina, (unknown), Gabriele Gamerith, Elisabeth Pechriggl, Julia Huber, Edith Lorenz, Jens M. Kelm, Wolfgang Hilbe, H. Zwierzina, Johann Kern	53
3	Small steps of improvement in small-cell lung cancer (SCLC) within two decades: A comprehensive analysis of 484 patients 2014 ·Lung Cancer ·Michael Fiegl, Andreas Pircher, (unknown), Gabriele Gamerith, Florian Kocher, Georg Pall, (unknown), Thomas Schmid, William Sterlacci, Herbert Jamnig, (unknown), August Zabernigg, W. Oberaigner, Wolfgang Hilbe	23
4	Development of an Innovative 3D Cell Culture System to Study Tumour - Stroma Interactions in Non-Small Cell Lung Cancer Cells 2014 ·PLoS ONE ·Arno Amann, Marit Zwierzina, Gabriele Gamerith, Mario Bitsche, Julia Huber, Georg F. Vogel, Michael Blumer, (unknown), Elisabeth Pechriggl, Jens M. Kelm, Wolfgang Hilbe, H. Zwierzina	130
5	Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants 2012 ·Journal of Breath Research ·Wojciech Filipiak, Veronika Ruzsányi, Paweł Mochalski, Anna Filipiak, (unknown), Clemens Ager, H. Denz, Wolfgang Hilbe, Herbert Jamnig, Martin Hackl, Alexander Dzien, A Amann	172
6	High transforming growth factor β expression represents an important prognostic parameter for surgically resected non–small cell lung cancer 2011 ·Human Pathology ·William Sterlacci, Dominik Wolf‎, Spasenija Savic, Wolfgang Hilbe, Thomas Schmid, Herbert Jamnig, Michael Fiegl, Alexandar Tzankov	35
7	Histologie-basierter Algorithmus der molekularen Diagnostik des epidermalen Wachstumsfaktor-Rezeptorgens (Epidermal Growth Factor Receptor, EGFR) beim nicht-kleinzelligen Lungenkarzinom (non-small cell lung cancer, NSCLC)* 2011 ·Wiener klinische Wochenschrift ·(unknown), Helmut Popper, Fritz Wrba, Ulrike Gruber-Moesenbacher, Wolfgang Hulla, Robert Pirker, Wolfgang Hilbe, Michael Studnicka, Andrea Mohn-Staudner, Ferdinand Ploner	6
8	Cancer Stem Cells: Characteristics and Their Potential Role for New Therapeutic Strategies 2011 ·Onkologie ·Stephan Bohl, Andreas Pircher, Wolfgang Hilbe	16
9	Endothelial Progenitor Cells: Current Issues on Characterization and Challenging Clinical Applications 2011 ·Stem Cell Reviews and Reports ·Thomas Resch, Andreas Pircher, Christian M. Kähler, Johann Pratschke, Wolfgang Hilbe	40
10	Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients 2010 ·Journal of Thoracic Oncology ·William Sterlacci, Michael Fiegl, Wolfgang Hilbe, Herbert Jamnig, Wilhelm Oberaigner, Thomas Schmid, Florian Augustin, Jutta Auberger, Ellen C. Obermann, Alexandar Tzankov	43
11	Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up study 2009 ·Annals of Oncology ·Alexander Strasak, Ruth M. Pfeiffer, Larry J. Brant, Kilian Rapp, Wolfgang Hilbe, Willi Oberaigner, Siegfried Lang, Wegene Borena, Hans Concin, Gabriel Diem, Elfriede Ruttmann, Bernhard Glodny, Karl Pfeiffer, Hanno Ulmer	67
12	Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases 2009 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·William Sterlacci, Michael Fiegl, Wolfgang Hilbe, Jutta Auberger, Gregor Mikuz, Alexandar Tzankov	50
13	Association of γ-Glutamyltransferase and Risk of Cancer Incidence in Men: A Prospective Study 2008 ·Cancer Research ·Alexander Strasak, Kilian Rapp, Larry J. Brant, Wolfgang Hilbe, Martin Gregory, Willi Oberaigner, Elfriede Ruttmann, Hans Concin, Günter Diem, Karl Pfeiffer, Hanno Ulmer, (unknown)	102
14	Prospective study of the association of gamma‐glutamyltransferase with cancer incidence in women 2008 ·International Journal of Cancer ·Alexander Strasak, Ruth M. Pfeiffer, Jochen Klenk, Wolfgang Hilbe, Willi Oberaigner, Martin Gregory, Hans Concin, Günter Diem, Karl Pfeiffer, Elfriede Ruttmann, Hanno Ulmer, (unknown)	87
15	Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury 2007 ·Respiratory Research ·Christian M. Kähler, (unknown), Wolfgang Hilbe, Andreas Gschwendtner, Daniela Colleselli, Harald Niederegger, Eva‐Maria Boneberg, Gilbert Spizzo, Albrecht Wendel, Eberhard Gunsilius, Josef R. Patsch, Jürg Hamacher	82
16	Increased CD133 expression in bone marrow of myelodysplastic syndromes 2005 ·Leukemia Research ·Jutta Auberger, Margit Dlaska, (unknown), Eberhard Gunsilius, Ewald Wöll, Wolfgang Hilbe	7
17	Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors 2000 ·Bone Marrow Transplantation ·Wolfgang Hilbe, Walter Nußbaumer, Hugo Bonatti, J. Thaler, Dietger Niederwieser, David Nachbaur	13
18	Detection and quantitation of genetically marked acute myeloid leukemia by competitive polymerase chain reaction after autologous bone marrow transplantation 1999 ·Experimental Hematology ·Thomas Kühr, Oliver Bechter, Stephan Geley, Wolfgang Eisterer, (unknown), (unknown), Hermann Dietrich, Wolfgang Hilbe, Reinhard Kofler, Josef Thaler	3
19	Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: A new strategy for remission assessment 1998 ·Genes Chromosomes and Cancer ·(unknown), (unknown), Wolfgang Hilbe, Oliver Bechter, Martin Erdel, Gerd Utermann, Hans‐Christoph Duba	43
20	Decreased potency of MDR‐modulators under serum conditions determined by a functional assay 1995 ·British Journal of Haematology ·Christof Ludescher, Wolfgang Eisterer, Wolfgang Hilbe, Johann Hofmann, Josef Thaler	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact